Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Merloni

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancers|January 8, 2023
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast CancerCaterina Gianni, Michela Palleschi, Filippo Merloni, et al.
Frontiers in Oncology|August 25, 2022
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatmentCaterina Gianni, Michela Palleschi, Giuseppe Schepisi, et al.
BJUI Compass|April 13, 2026
Juan Morote, Berta Miró, Lucas Regis, et al.
Tumori|June 4, 2026
Multiparametric whole-body magnetic resonance imaging in breast cancer management: A prospective studyMichela Palleschi, Filippo Merloni, Andrea Prochowski Iamurri, et al.
International Journal of Medical Informatics|January 10, 2026
Survey on cancer patients' attitudes towards AI and data protection: A cross-sectional study from an Italian cancer centerMartina Cavallucci, Alice Andalò, Valentina Danesi, et al.
Frontiers in Oncology|February 16, 2023
Locoregional treatment of <i>de novo</i> stage IV breast cancer in the era of modern oncologyFilippo Merloni, Michela Palleschi, Caterina Gianni, et al.
Clinical & Experimental Metastasis|September 23, 2024
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectivesFilippo Merloni, Michela Palleschi, Caterina Gianni, et al.
Cancers|November 27, 2025
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future DirectionsSamanta Sarti, Alessandro Adriano Viansone, Olga Serra, et al.
Clinical Breast Cancer|August 6, 2019
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer PatientsLuca Cantini, Mirco Pistelli, Filippo Merloni, et al.
Critical Reviews in Oncology/Hematology|December 24, 2022
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectivesMarianna Sirico, Alessandra Virga, Benedetta Conte, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancers|January 8, 2023
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast CancerCaterina Gianni, Michela Palleschi, Filippo Merloni, et al.
Frontiers in Oncology|August 25, 2022
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatmentCaterina Gianni, Michela Palleschi, Giuseppe Schepisi, et al.
BJUI Compass|April 13, 2026
Juan Morote, Berta Miró, Lucas Regis, et al.
Tumori|June 4, 2026
Multiparametric whole-body magnetic resonance imaging in breast cancer management: A prospective studyMichela Palleschi, Filippo Merloni, Andrea Prochowski Iamurri, et al.
International Journal of Medical Informatics|January 10, 2026
Survey on cancer patients' attitudes towards AI and data protection: A cross-sectional study from an Italian cancer centerMartina Cavallucci, Alice Andalò, Valentina Danesi, et al.
Frontiers in Oncology|February 16, 2023
Locoregional treatment of <i>de novo</i> stage IV breast cancer in the era of modern oncologyFilippo Merloni, Michela Palleschi, Caterina Gianni, et al.
Clinical & Experimental Metastasis|September 23, 2024
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectivesFilippo Merloni, Michela Palleschi, Caterina Gianni, et al.
Cancers|November 27, 2025
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future DirectionsSamanta Sarti, Alessandro Adriano Viansone, Olga Serra, et al.
Clinical Breast Cancer|August 6, 2019
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer PatientsLuca Cantini, Mirco Pistelli, Filippo Merloni, et al.
Critical Reviews in Oncology/Hematology|December 24, 2022
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectivesMarianna Sirico, Alessandra Virga, Benedetta Conte, et al.
Pageof 3